Company Description
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands.
The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers.
It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online.
Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025.
The company is headquartered in Toronto, Canada.
| Country | Canada |
| Founded | 2013 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,120 |
| CEO | James Yamanaka |
Contact Details
Address: 145 King Street West, Suite #1400 Toronto, ON M5H 1J8 Canada | |
| Phone | 844 644 4726 |
| Website | organigram.ca |
Stock Details
| Ticker Symbol | OGI |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| CIK Code | 1620737 |
| CUSIP Number | 68617J100 |
| ISIN Number | CA68617J1003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Peter L. Amirault | Executive Chairman |
| Greg Guyatt C.A., CPA | Chief Financial Officer |
| Helen Martin | Chief Legal Officer and Corporate Secretary |
| Timothy Emberg | President of Organigram Canada |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 20, 2026 | 6-K | Report of foreign issuer |
| Aug 11, 2026 | 6-K | Report of foreign issuer |
| Aug 4, 2026 | 6-K | Report of foreign issuer |
| Jul 20, 2026 | 6-K | Report of foreign issuer |
| May 12, 2026 | 6-K | Report of foreign issuer |
| May 6, 2026 | 6-K | Report of foreign issuer |
| Apr 17, 2026 | SCHEDULE 13D/A | Filing |
| Apr 16, 2026 | 6-K | Report of foreign issuer |
| Mar 31, 2026 | 6-K | Report of foreign issuer |
| Mar 23, 2026 | 6-K | Report of foreign issuer |